RERE ATRenew
ATRenew earnings company data as of 4:49 AM ET 10/23
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 19 Nov | EPS | 0.10 | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 20 Aug | EPS | 0.58 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by RERE's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $19K sold by 1 insider outside a trading plan
- None no planned (10b5-1) sales
-
Rui Zhu DirectorSale$19K 4,762 shares at $4.00 7.9% of stakeTraded Jun 10 Filed Jun 11
Also filed in the last 12 months, not counted as buying or selling: 5 option exercises.
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 20-F | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 20-F | Filing Doc | ||
| 6-K | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| 6-K | Filing Doc | ||
| SC 13G/A | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 20-F | Filing Doc | ||
| 6-K | Filing Doc | ||
| SC 13G/A | — | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.